Back
Ares Dynamic Credit Allocation Fund Vs. Ascendis Pharma A/S Industry Stock Comparison
Sell
26
ARDC
Ares Dynamic Credit Allocation Fund
Last Price:
$11.97
Seasonality Move:
3.04%
Sell
48
ASND
Ascendis Pharma A/S
Last Price:
$229.15
Seasonality Move:
-1.81%
Sell
26
Ares Dynamic Credit Allocation Fund (ARDC)
is a Sell
Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?
-
The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $11.98. The Score for ARDC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
ARDC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
-
The current Ascendis Pharma A/S [ASND] share price is $229.25. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARDC Stock Price Chart
What is Ares Dynamic Credit Allocation Fund's stock price today?
-
The Ares Dynamic Credit Allocation Fund share price today is $11.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARDC is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $229.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARDC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 36.8 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.02 - 12.44) | Sell |
| Bollinger Bands (100): | (12.56 - 13.68) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 53.82 | Buy |
| Chaikin Money Flow: | 686129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (220.8 - 237.28) | Buy |
| Bollinger Bands (100): | (206.49 - 229.63) | Buy |
ARDC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.06 | Sell |
| 20-day SMA: | 12.15 | Sell |
| 50-day SMA: | 12.75 | Sell |
| 200-day SMA: | 13.67 | Sell |
| 8-day EMA: | 12.06 | Sell |
| 20-day EMA: | 12.21 | Sell |
| 50-day EMA: | 12.6 | Sell |
| 200-day EMA: | 13.44 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 222.32 | Buy |
| 20-day SMA: | 226.62 | Buy |
| 50-day SMA: | 227.54 | Buy |
| 200-day SMA: | 204.27 | Buy |
| 8-day EMA: | 224.85 | Buy |
| 20-day EMA: | 225.59 | Buy |
| 50-day EMA: | 224.53 | Buy |
| 200-day EMA: | 204.4 | Buy |
Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.81 per share, an increase next quarter of $0.15 per share, an increase this year of $9.02 per share, and an increase next year of $7.49 per share.
Ares Dynamic Credit Allocation Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||